Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast tumour angiogenesis.

Stephen B Fox1, Daniele G Generali, Adrian L Harris

  • 1Pathology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, 3002, Australia. stephen.fox@petermac.org

Breast Cancer Research : BCR
|January 15, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generating exosome subtypes: diverse membrane origins and mergers.

Trends in cell biology·2026
Same author

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma.

Cancer research·2026
Same author

Editorial Expression of Concern: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Nature medicine·2026
Same author

A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.

Communications medicine·2025
Same author

Tumor-specific CD8 T cell characterization in HR<sup>+</sup> breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.

Cell reports. Medicine·2025
Same author

Amyloid-β disrupts APP-regulated protein aggregation and dissociation from recycling endosomal membranes.

The EMBO journal·2025
Same journal

Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer.

Breast cancer research : BCR·2026
Same journal

Exploring LTB-mediated T cell differentiation as a prognostic marker in triple-negative breast cancer.

Breast cancer research : BCR·2026
Same journal

Intraoperative NIR-II fluorescence guidance for precise tumor margin assessment and maximized tissue preservation in breast surgery.

Breast cancer research : BCR·2026
Same journal

Tumour-based DNA methylation markers of breast cancer survival: a pooled analysis of 2157 cases.

Breast cancer research : BCR·2026
Same journal

Comprehensive comparison of homologous recombination deficiency predictors in early-stage triple-negative breast cancer.

Breast cancer research : BCR·2026
Same journal

Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM study.

Breast cancer research : BCR·2026
See all related articles

Tumour neovascularization is crucial in breast cancer development and progression. This review details its mechanisms, the tumor microenvironment

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumour neovascularization plays a central role in both in situ and invasive breast cancer.
  • Clinical trials of antiangiogenic therapy highlight the significance of tumour neovascularization in breast cancer treatment.

Purpose of the Study:

  • To provide a background on breast tumour neovascularization.
  • To outline the mechanisms driving tumour neovascularization.
  • To discuss the influence of the tumor microenvironment, particularly hypoxia, on angiogenesis.
  • To summarize the regulation of angiogenesis and available antivascular agents for antiangiogenic therapy.

Main Methods:

  • Literature review of existing research on breast tumour neovascularization.
  • Analysis of mechanisms involved in angiogenesis.

Related Experiment Videos

  • Discussion of the tumor microenvironment's role, with a focus on hypoxia.
  • Summary of regulatory pathways of angiogenesis.
  • Overview of conventional and novel antivascular agents and their dosing schedules.

    • Main Results:

    • Tumour neovascularization is a complex process involving multiple mechanisms.
    • The tumor microenvironment, especially hypoxia, significantly influences angiogenesis.
    • Various antivascular agents are available for antiangiogenic therapy in breast cancer.

    Conclusions:

    • Understanding tumour neovascularization mechanisms and the tumor microenvironment is vital for effective breast cancer treatment.
    • Antiangiogenic therapy, utilizing various antivascular agents, is a key strategy in managing breast cancer.
    • Further research into novel agents and optimal dosing schedules is warranted.